(Q51548110)

6 April 2018

title

Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium. (English)

1 reference

6 April 2018

1 reference

1 reference

Miao L

1

1 reference

6 April 2018

Perreault CL

series ordinal

2

1 reference

6 April 2018

Travers KE

series ordinal

3

1 reference

6 April 2018

Morgan JP

series ordinal

4

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

6 April 2018

European Journal of Pharmacology

published in

1 reference

6 April 2018

volume

321

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

201-208

1 reference

6 April 2018

Mechanism of direct cardiostimulating actions of hydralazine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Future directions in vasodilator therapy for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Cardiovascular effects of milrinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Flosequinan: a vasodilator with positive inotropic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Clinical efficacy of flosequinan in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Effect of flosequinan on exercise capacity and symptoms in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Effect of flosequinan upon isoenzymes of phosphodiesterase from guinea-pig cardiac and vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Different effects of alpha- and beta-adrenergic stimulation on cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Mechanism of action of hydralazine on vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Inhibitors of sodium-calcium exchange: identification and development of probes of transport activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Cyclic adenosine monophosphate effects on the myocardium: A man who blows hot and cold with one breath

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

A comparative study of three methods for intracellular loading of the calcium indicator aequorin in ferret papillary muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Direct vasodilators with unknown modes of action: the nitro-compounds and hydralazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Abnormal Intracellular Modulation of Calcium as a Major Cause of Cardiac Contractile Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Metabolic consequences and predictability of ventricular fibrillation in hypoxia. A 31P- and 23Na-nuclear magnetic resonance study of the isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

The effects of cocaine on intracellular Ca2+ handling and myofilament Ca2+ responsiveness of ferret ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Sodium-calcium exchange in plasma membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Flosequinan, a vasodilator with a novel mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Inhibition of Na+/Ca2+ exchange in membrane vesicle and papillary muscle preparations from guinea pig heart by analogs of amiloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Endothelial mechanism in the vascular action of hydralazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Pharmacology of flosequinan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

Pharmacological analyses of hydralazine-induced cardiac action in intact dogs and isolated, blood-perfused canine atria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900946-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(96)00946-6

1 reference

6 April 2018

release_yqwtx2r3rff63nw4m6ovihumqa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqwtx2r3rff63nw4m6ovihumqa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

6 April 2018